Published on Institute for Health Metrics and Evaluation (https://www.healthdata.org)

Home > Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study

Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study [1]

Abstract

Between 2012 and 2016, development assistance for HIV/AIDS decreased by 20.0%; domestic financing is therefore critical to sustaining the response to HIV/AIDS. To understand whether domestic resources could fill the financing gaps created by declines in development assistance, we aimed to track spending on HIV/AIDS and estimated the potential for governments to devote additional domestic funds to HIV/AIDS.

Methods 

We extracted 8,589 data points reporting spending on HIV/AIDS. We used spatiotemporal Gaussian process regression to estimate a complete time series of spending by domestic sources (government, prepaid private, and out-of-pocket) and spending category (prevention, and care and treatment) from 2000 to 2016 for 137 low-income and middle-income countries (LMICs). Development assistance data for HIV/AIDS were from Financing Global Health 2018, and HIV/AIDS prevalence, incidence, and mortality were from the Global Burden of Disease study 2017. We used stochastic frontier analysis to estimate potential additional government spending on HIV/AIDS, which was conditional on the current government health budget and other finance, economic, and contextual factors associated with HIV/AIDS spending. All spending estimates were reported in 2018 US dollars.

Findings 

Between 2000 and 2016, total spending on HIV/AIDS in LMICs increased from $4.0 billion (95% uncertainty interval 2.9–6.0) to $19.9 billion (15.8–26.3), spending on HIV/AIDS prevention increased from $596 million (258 million to 1.3 billion) to $3.0 billion (1.5–5.8), and spending on HIV/AIDS care and treatment increased from $1.1 billion (458.1 million to 2.2 billion) to $7.2 billion (4.3–11.8). Over this time period, the share of resources sourced from development assistance increased from 33.2% (21.3–45.0) to 46.0% (34.2–57.0). Care and treatment spending per year on antiretroviral therapy varied across countries, with an IQR of $284–2,915. An additional $12.1 billion (8.4–17.5) globally could be mobilized by governments of LMICs to finance the response to HIV/AIDS. Most of these potential resources are concentrated in ten middle-income countries (Argentina, China, Colombia, India, Indonesia, Mexico, Nigeria, Russia, South Africa, and Vietnam).

Interpretation 

Some governments could mobilize more domestic resources to fight HIV/AIDS, which could free up additional development assistance for many countries without this ability, including many low-income, high-prevalence countries. However, a large gap exists between available financing and the funding needed to achieve global HIV/AIDS goals, and sustained and coordinated effort across international and domestic development partners is required to end AIDS by 2030.

Citation: 

Haakenstad A, Moses MW, Tao T, Tsakalos G, Zlavog B, Kates J, Wexler A, Murray CJL, Dieleman JL. Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study. The Lancet HIV. 24 April 2019. doi: http://dx.doi.org/10.1016/S1473-3099 [2](19)30165-3

Related Documents: 
Tracking spending on malaria by source in 106 countries, 2000–16: an economic modelling study [3]
Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050 [4]
Financing Global Health 2018: Countries and Programs in Transition [5]
Increased out-of-pocket spending threatens universal health coverage in ‘missing middle’ countries [6]
Household malaria spending, 2000–2016 [7]
Datasets: 
Datasets [8]
People: 
Annie Haakenstad [9]
Joseph Dieleman [10]
Christopher J.L. Murray [11]
Golsum Tsakalos [12]
Topics: 
Health Financing
HIV/AIDS

Links
[1] https://www.healthdata.org/research-article/potential-additional-government-spending-hivaids-137-low-income-and-middle-income [2] http://dx.doi.org/10.1016/S1473-3099 [3] https://www.healthdata.org/research-article/tracking-spending-malaria-source-106-countries-2000%E2%80%9316-economic-modelling-study [4] https://www.healthdata.org/research-article/past-present-and-future-global-health-financing-review-development-assistance [5] https://www.healthdata.org/policy-report/financing-global-health-2018-countries-and-programs-transition [6] https://www.healthdata.org/news-release/increased-out-pocket-spending-threatens-universal-health-coverage-%E2%80%98missing-middle%E2%80%99 [7] https://www.healthdata.org/video/household-malaria-spending-2000%E2%80%932016 [8] http://ghdx.healthdata.org/node/401154 [9] https://www.healthdata.org/about/annie-haakenstad [10] https://www.healthdata.org/about/joseph-dieleman [11] https://www.healthdata.org/about/christopher-jl-murray [12] https://www.healthdata.org/about/golsum-tsakalos